EditorialPredicting Patient Outcome in the Evolving Field of Malignant Pleural EffusionGleeson, Laura E. MBChB, BAO, PhD*,†; Gary Lee, Y.C. MBChB, PhD, FCCP, FRCP, FRACP‡,§Author Information *Department of Clinical Medicine, St. James’s Hospital †Department of Clinical Medicine, School of Medicine, Trinity College Dublin, Dublin, Ireland ‡Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands §Centre for Respiratory Health, School of Medicine, University of Western Australia, Perth, WA, Australia Y.C.G.L. is an Australian Medical Research Future Fund Practitioner Fellow. He has received research project grant funding from the National Health Medical Research Council of Australia, New South Wales Dust Disease Board, Sir Charles Gairdner Research Advisory Committee, and the Cancer Council of Western Australia. Disclosure: Y.C.G.L. has served on the advisory board of BD/CareFusion. He has led clinical trials, which received free drainage kits (for participants) and unrestricted educational grants from Rocket Med Plc. L.E.G. has no conflict of interest or other disclosures. Reprints: Y.C. Gary Lee, MBChB, PhD, FCCP, FRCP, FRACP, Centre for Respiratory Health, School of Medicine, 533 Harry Perkins Building, QE II Medical Centre, University of Western Australia, Perth, WA 6009, Australia (e-mail: email@example.com). Online date: October 30, 2019 Journal of Bronchology & Interventional Pulmonology: January 2020 - Volume 27 - Issue 1 - p 1-3 doi: 10.1097/LBR.0000000000000630 Buy Metrics Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.